Public Insurance Status is Associated With Lower Bracing Treatment Success in Infants With Developmental Dysplasia of

Jayna Lenders1, Pranav Rajaram1, Brandon W Henry2

  • 1University of Michigan Medical School.

Insights

Children with developmental dysplasia of the hip (DDH) with public insurance present later and have worse bracing outcomes. Public insurance is a key indicator for identifying at-risk DDH patients needing early support.

Area of Science:

  • Pediatric Orthopedics
  • Health Disparities Research
  • Developmental Dysplasia of the Hip (DDH)

Background:

  • Early diagnosis and bracing are crucial for resolving developmental dysplasia of the hip (DDH).
  • Delayed diagnosis or bracing failure often leads to surgical intervention.
  • Socioeconomic factors can influence diagnosis timing and treatment invasiveness for DDH.

Purpose of the Study:

  • To investigate the association between health disparity measures and bracing outcomes in children with DDH.
  • To determine if socioeconomic factors correlate with treatment progression in DDH patients.

Main Methods:

  • Retrospective review of 401 pediatric patients diagnosed with DDH between 2013 and 2021.
  • Data collected included demographics, Area Deprivation Index (ADI), insurance type, and treatment course.
  • Statistical analysis assessed the impact of socioeconomic factors on DDH treatment outcomes.

Main Results:

  • Patients with higher socioeconomic disadvantage (ADI 5-10) were more likely to have public insurance and missed appointments.
  • Higher socioeconomic disadvantage correlated with increased treatment progression (failed bracing, surgery) and loss to follow-up.
  • Public insurance predicted older age at presentation, greater treatment progression, and higher need for surgery.

Conclusions:

  • Children with DDH and public insurance were diagnosed later and had higher rates of bracing failure.
  • Public insurance is a significant indicator of health disparities in DDH care.
  • Early social work support may benefit DDH patients with public insurance at risk for conservative treatment failure.
Abstract